Literature DB >> 22378061

Chronic inflammation, immune escape, and oncogenesis in the liver: a unique neighborhood for novel intersections.

Jimmy K Stauffer1, Anthony J Scarzello, Qun Jiang, Robert H Wiltrout.   

Abstract

Sustained hepatic inflammation, driven by alcohol consumption, nonalcoholic fatty liver disease, and/or chronic viral hepatitis (hepatitis B and C), results in damage to parenchyma, oxidative stress, and compensatory regeneration/proliferation. There is substantial evidence linking these inflammation-associated events with the increased incidence of hepatocellular carcinogenesis. Although acute liver inflammation can play a vital and beneficial role in response to liver damage or acute infection, the effects of chronic liver inflammation, including liver fibrosis and cirrhosis, are sufficient in a fraction of individuals to initiate the process of transformation and the development of hepatocellular carcinoma. This review highlights immune-dependent mechanisms that may be associated with hepatocellular oncogenesis, including critical transformative events/pathways in the context of chronic inflammation and subverted tolerogenesis.
Copyright © 2012 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2012        PMID: 22378061      PMCID: PMC3381981          DOI: 10.1002/hep.25674

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  59 in total

Review 1.  Free radicals and antioxidants in normal physiological functions and human disease.

Authors:  Marian Valko; Dieter Leibfritz; Jan Moncol; Mark T D Cronin; Milan Mazur; Joshua Telser
Journal:  Int J Biochem Cell Biol       Date:  2006-08-04       Impact factor: 5.085

Review 2.  The role of cytokines in hepatocellular carcinoma.

Authors:  Anuradha Budhu; Xin Wei Wang
Journal:  J Leukoc Biol       Date:  2006-08-31       Impact factor: 4.962

Review 3.  The liver as an immunological organ.

Authors:  Vito Racanelli; Barbara Rehermann
Journal:  Hepatology       Date:  2006-02       Impact factor: 17.425

4.  Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas.

Authors:  Wen Xue; Lars Zender; Cornelius Miething; Ross A Dickins; Eva Hernando; Valery Krizhanovsky; Carlos Cordon-Cardo; Scott W Lowe
Journal:  Nature       Date:  2007-01-24       Impact factor: 49.962

5.  Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection.

Authors:  C Bain; A Fatmi; F Zoulim; J P Zarski; C Trépo; G Inchauspé
Journal:  Gastroenterology       Date:  2001-02       Impact factor: 22.682

6.  Endotoxin modulates the capacity of CpG-activated liver myeloid DC to direct Th1-type responses.

Authors:  Masanori Abe; Daisuke Tokita; Giorgio Raimondi; Angus W Thomson
Journal:  Eur J Immunol       Date:  2006-09       Impact factor: 5.532

7.  Genomic modeling of tumor onset and progression in a mouse model of aggressive human liver cancer.

Authors:  Cédric Coulouarn; Valentina M Factor; Elizabeth A Conner; Snorri S Thorgeirsson
Journal:  Carcinogenesis       Date:  2011-07-18       Impact factor: 4.944

8.  Hepatitis C virus (HCV) core protein-induced, monocyte-mediated mechanisms of reduced IFN-alpha and plasmacytoid dendritic cell loss in chronic HCV infection.

Authors:  Angela Dolganiuc; Serena Chang; Karen Kodys; Pranoti Mandrekar; Gennadiy Bakis; Maureen Cormier; Gyongyi Szabo
Journal:  J Immunol       Date:  2006-11-15       Impact factor: 5.422

Review 9.  Interleukin-10-secreting type 1 regulatory T cells in rodents and humans.

Authors:  Maria Grazia Roncarolo; Silvia Gregori; Manuela Battaglia; Rosa Bacchetta; Katharina Fleischhauer; Megan K Levings
Journal:  Immunol Rev       Date:  2006-08       Impact factor: 12.988

10.  Interleukin-10 production by effector T cells: Th1 cells show self control.

Authors:  Giorgio Trinchieri
Journal:  J Exp Med       Date:  2007-02-12       Impact factor: 14.307

View more
  46 in total

1.  JUNB/AP-1 controls IFN-γ during inflammatory liver disease.

Authors:  Martin K Thomsen; Latifa Bakiri; Sebastian C Hasenfuss; Rainer Hamacher; Lola Martinez; Erwin F Wagner
Journal:  J Clin Invest       Date:  2013-11-08       Impact factor: 14.808

Review 2.  Genetic risk markers for hepatocellular carcinoma in patients with alcoholic liver disease.

Authors:  Pierre Nahon; Angela Sutton; Marianne Ziol; Jessica Zucman-Rossi; Jean-Claude Trinchet; Nathalie Ganne-Carrié
Journal:  Hepat Oncol       Date:  2015-01-12

Review 3.  Liver function and dysfunction - a unique window into the physiological reach of ER stress and the unfolded protein response.

Authors:  D Thomas Rutkowski
Journal:  FEBS J       Date:  2018-02-07       Impact factor: 5.542

4.  Altered mucosal DNA methylation in parallel with highly active Helicobacter pylori-related gastritis.

Authors:  Takeichi Yoshida; Jun Kato; Takao Maekita; Satoshi Yamashita; Shotaro Enomoto; Takayuki Ando; Tohru Niwa; Hisanobu Deguchi; Kazuki Ueda; Izumi Inoue; Mikitaka Iguchi; Hideyuki Tamai; Toshikazu Ushijima; Masao Ichinose
Journal:  Gastric Cancer       Date:  2013-01-06       Impact factor: 7.370

5.  β-Catenin signaling in hepatocellular cancer: Implications in inflammation, fibrosis, and proliferation.

Authors:  Jung Min Lee; Jing Yang; Pippa Newell; Sucha Singh; Anil Parwani; Scott L Friedman; Kari Nichole Nejak-Bowen; Satdarshan P Monga
Journal:  Cancer Lett       Date:  2013-09-23       Impact factor: 8.679

6.  PATHOGENESIS OF HEPATOCELLULAR CARCINOMA DEVELOPMENT IN NON ALCOHOLIC FATTY LIVER DISEASE.

Authors:  Kirti Shetty; Jian Chen; Ji-Hyun Shin; Wilma Jogunoori; Lopa Mishra
Journal:  Curr Hepatol Rep       Date:  2015-06

7.  HMGB1 promotes ductular reaction and tumorigenesis in autophagy-deficient livers.

Authors:  Bilon Khambu; Nazmul Huda; Xiaoyun Chen; Daniel J Antoine; Yong Li; Guoli Dai; Ulrike A Köhler; Wei-Xing Zong; Satoshi Waguri; Sabine Werner; Tim D Oury; Zheng Dong; Xiao-Ming Yin
Journal:  J Clin Invest       Date:  2018-05-07       Impact factor: 14.808

8.  MicroRNAs control hepatocarcinogenesis by regulating hepatocyte nuclear factor 4α-inflammatory signal feedback loops.

Authors:  Hua Wang; Bin Gao
Journal:  Hepatology       Date:  2014-09-29       Impact factor: 17.425

9.  Hepatitis C virus-related hepatocellular carcinoma: An insight into molecular mechanisms and therapeutic strategies.

Authors:  Denis Selimovic; Abdelouahid El-Khattouti; Hanan Ghozlan; Youssef Haikel; Ola Abdelkader; Mohamed Hassan
Journal:  World J Hepatol       Date:  2012-12-27

10.  Infection with the carcinogenic liver fluke Opisthorchis viverrini modifies intestinal and biliary microbiome.

Authors:  Jordan L Plieskatt; Raksawan Deenonpoe; Jason P Mulvenna; Lutz Krause; Banchob Sripa; Jeffrey M Bethony; Paul J Brindley
Journal:  FASEB J       Date:  2013-08-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.